The same experiment also demonstrated that two genotypes, CC of IL-6 and GG of STAT3, were overexpressed in the CTCL patients, determining an increased risk of malignancy development. The gene discussed is STAT3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.